BLCO
Price
$15.68
Change
-$0.92 (-5.54%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
5.56B
103 days until earnings call
Intraday BUY SELL Signals
CRL
Price
$169.21
Change
-$2.29 (-1.34%)
Updated
Nov 13 closing price
Capitalization
8.33B
96 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

BLCO vs CRL

Header iconBLCO vs CRL Comparison
Open Charts BLCO vs CRLBanner chart's image
Bausch + Lomb
Price$15.68
Change-$0.92 (-5.54%)
Volume$4.2K
Capitalization5.56B
Charles River Laboratories International
Price$169.21
Change-$2.29 (-1.34%)
Volume$1.14M
Capitalization8.33B
BLCO vs CRL Comparison Chart in %
BLCO
Daily Signal:
Gain/Loss:
CRL
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
BLCO vs. CRL commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BLCO is a Hold and CRL is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (BLCO: $15.69 vs. CRL: $169.21)
Brand notoriety: BLCO and CRL are both not notable
BLCO represents the Pharmaceuticals: Other, while CRL is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: BLCO: 177% vs. CRL: 108%
Market capitalization -- BLCO: $5.56B vs. CRL: $8.33B
BLCO [@Pharmaceuticals: Other] is valued at $5.56B. CRL’s [@Medical Specialties] market capitalization is $8.33B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $200.47B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $12B. The average market capitalization across the [@Medical Specialties] industry is $12.08B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BLCO’s FA Score shows that 1 FA rating(s) are green whileCRL’s FA Score has 1 green FA rating(s).

  • BLCO’s FA Score: 1 green, 4 red.
  • CRL’s FA Score: 1 green, 4 red.
According to our system of comparison, BLCO is a better buy in the long-term than CRL.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BLCO’s TA Score shows that 5 TA indicator(s) are bullish while CRL’s TA Score has 4 bullish TA indicator(s).

  • BLCO’s TA Score: 5 bullish, 4 bearish.
  • CRL’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, BLCO is a better buy in the short-term than CRL.

Price Growth

BLCO (@Pharmaceuticals: Other) experienced а +1.03% price change this week, while CRL (@Medical Specialties) price change was -0.98% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.10%. For the same industry, the average monthly price growth was +0.50%, and the average quarterly price growth was +6.41%.

The average weekly price growth across all stocks in the @Medical Specialties industry was +1.21%. For the same industry, the average monthly price growth was +1.82%, and the average quarterly price growth was +31.26%.

Reported Earning Dates

BLCO is expected to report earnings on Feb 25, 2026.

CRL is expected to report earnings on Feb 18, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (+2.10% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (+1.21% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRL($8.33B) has a higher market cap than BLCO($5.56B). CRL YTD gains are higher at: -7.096 vs. BLCO (-8.084). CRL has higher annual earnings (EBITDA): 528M vs. BLCO (454M). BLCO has more cash in the bank: 266M vs. CRL (183M). CRL has less debt than BLCO: CRL (2.79B) vs BLCO (4.96B). BLCO has higher revenues than CRL: BLCO (4.89B) vs CRL (4.03B).
BLCOCRLBLCO / CRL
Capitalization5.56B8.33B67%
EBITDA454M528M86%
Gain YTD-8.084-7.096114%
P/E RatioN/A577.05-
Revenue4.89B4.03B121%
Total Cash266M183M145%
Total Debt4.96B2.79B178%
FUNDAMENTALS RATINGS
CRL: Fundamental Ratings
CRL
OUTLOOK RATING
1..100
73
VALUATION
overvalued / fair valued / undervalued
1..100
94
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
91
PRICE GROWTH RATING
1..100
49
P/E GROWTH RATING
1..100
1
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BLCOCRL
RSI
ODDS (%)
Bearish Trend 3 days ago
74%
Bearish Trend 3 days ago
68%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
77%
Bullish Trend 3 days ago
67%
Momentum
ODDS (%)
Bullish Trend 3 days ago
66%
Bearish Trend 3 days ago
75%
MACD
ODDS (%)
Bullish Trend 3 days ago
59%
Bearish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
70%
Bullish Trend 3 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
75%
Bullish Trend 3 days ago
69%
Advances
ODDS (%)
Bullish Trend 3 days ago
67%
Bullish Trend 4 days ago
70%
Declines
ODDS (%)
Bearish Trend 18 days ago
72%
Bearish Trend 10 days ago
69%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
85%
Bullish Trend 3 days ago
69%
Aroon
ODDS (%)
Bullish Trend 3 days ago
73%
Bullish Trend 3 days ago
69%
View a ticker or compare two or three
Interact to see
Advertisement
BLCO
Daily Signal:
Gain/Loss:
CRL
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AOBLX12.950.04
+0.31%
Victory Pioneer Balanced A
PIIIX16.930.05
+0.30%
Principal Diversified Intl Inst
LONAX14.960.02
+0.13%
Longboard A
VWENX84.550.07
+0.08%
Vanguard Wellington Admiral
ACVIX9.88N/A
N/A
American Century Small Cap Value I

BLCO and

Correlation & Price change

A.I.dvisor indicates that over the last year, BLCO has been loosely correlated with CRL. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if BLCO jumps, then CRL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BLCO
1D Price
Change %
BLCO100%
+1.03%
CRL - BLCO
45%
Loosely correlated
-1.15%
MTD - BLCO
44%
Loosely correlated
+0.19%
RVTY - BLCO
44%
Loosely correlated
-0.19%
A - BLCO
43%
Loosely correlated
+1.41%
RMD - BLCO
43%
Loosely correlated
+0.17%
More

CRL and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRL has been closely correlated with IQV. These tickers have moved in lockstep 74% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRL jumps, then IQV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRL
1D Price
Change %
CRL100%
-1.15%
IQV - CRL
74%
Closely correlated
+1.08%
RVTY - CRL
62%
Loosely correlated
-0.19%
A - CRL
61%
Loosely correlated
+1.41%
MTD - CRL
59%
Loosely correlated
+0.19%
NOTV - CRL
58%
Loosely correlated
+5.66%
More